Company intelligence / Profile preview

Luna Genetics

Houston, Texas, United Stateslunagenetics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Luna Genetics has developed the Luna Prenatal Test—a noninvasive prenatal diagnostic that isolates fetal trophoblast cells from maternal blood as early as eight weeks gestation. This test provides comprehensive detection of chromosomal abnormalities with high resolution and eliminates the risks associated with invasive procedures like amniocentesis or CVS. The technology is positioned as a next-generation alternative to current noninvasive prenatal tests (NIPT), offering earlier and more accurate results[1][6].

Therapeutic areas: Women's Health
Modalities: DeviceDNA analysis (Diagnostics)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Luna Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luna Genetics.

Explore the full profile